Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece

NCT04084613 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.

NCT NCT04084613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04084613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece
Lead sponsor
Attikon Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2020
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

severe eosinophilic asthma